Navigating Parkinson Disease: Innovative Approaches to Mitigate OFF Episodes

Program Description

Parkinson disease is a common neurodegenerative disorder affecting approximately 1 million individuals in the United States. Treatment with oral levodopa initially provides rapid, robust, and long duration benefit, but as the disease progresses, the symptom benefit of each dose wanes, which can pose a clinical and economic burden on patients. This diminished effect of a levodopa dose has been termed an “OFF” episode, and these fluctuate with benefit (or “ON” periods) of subsequent doses. This webinar will provide pharmacists with a review of medication-related considerations to equip them in effectively managing OFF episodes and in making clinical recommendations tailored to patient needs while addressing drug-drug interactions and adherence. Through a collaborative, individualized approach to patient care and promoting patient education, pharmacists may be able to provide more effective approaches for identifying and treating OFF episodes in Parkinson disease with information about new therapies.

Target audience: Health-system, retail, consultant, and specialty pharmacists

Type of activity: Application
Release date: July 26, 2024
Expiration date: July 26, 2025

Time to complete activity: 1.0 hour

Learner level: Introductory
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore the underlying mechanisms, clinical signs, impact, and existing treatment hurdles associated with OFF episodes in Parkinson disease
• Identify the latest advancements in clinical practice, focusing on innovative therapeutic methods for addressing OFF episodes in Parkinson disease
• Examine the crucial role pharmacists play in enhancing outcomes related to OFF episodes in Parkinson disease through adept medication management and patient counseling strategies

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-215-H01-P. The activity is available for CE credit through July 26, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Jessa Marie Koch, PharmD, BCPP, APh

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Rose Buszka, PharmD, BCPS, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms